Genmab A/S
GNMSF
$249.00
-$0.45-0.18%
OTC PK
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -15.31% | -22.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.31% | -22.33% | |||
| Cost of Revenue | -19.75% | -12.79% | |||
| Gross Profit | -14.94% | -22.85% | |||
| SG&A Expenses | -20.19% | -29.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.67% | -11.65% | |||
| Operating Income | -7.41% | -41.97% | |||
| Income Before Tax | 34.55% | -52.60% | |||
| Income Tax Expenses | -12.50% | 241.10% | |||
| Earnings from Continuing Operations | 70.97% | -64.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 70.97% | -64.51% | |||
| EBIT | -7.41% | -41.97% | |||
| EBITDA | -3.56% | -40.58% | |||
| EPS Basic | 66.87% | -64.62% | |||
| Normalized Basic EPS | -50.99% | -57.40% | |||
| EPS Diluted | 65.93% | -64.39% | |||
| Normalized Diluted EPS | -50.37% | -57.12% | |||
| Average Basic Shares Outstanding | 2.46% | 0.31% | |||
| Average Diluted Shares Outstanding | 1.17% | -0.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||